Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Of mice and men: cancer gene discovery using comparative oncogenomics.

Tomlins SA, Chinnaiyan AM.

Cancer Cell. 2006 Jul;10(1):2-4.

PMID:
16843259
[PubMed - indexed for MEDLINE]
Free Article
2.

Cross-species oncogenomics in cancer gene identification.

Peeper D, Berns A.

Cell. 2006 Jun 30;125(7):1230-3.

PMID:
16814709
[PubMed - indexed for MEDLINE]
Free Article
3.

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, Mu D, Lucito R, Powers S, Lowe SW.

Cell. 2006 Jun 30;125(7):1253-67.

PMID:
16814713
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Tumor suppressor LATS1 is a negative regulator of oncogene YAP.

Hao Y, Chun A, Cheung K, Rashidi B, Yang X.

J Biol Chem. 2008 Feb 29;283(9):5496-509. Epub 2007 Dec 24.

PMID:
18158288
[PubMed - indexed for MEDLINE]
Free Article
5.

RNAi Delivers Insights into Liver Cancer.

Bernards R.

Cell. 2008 Nov 28;135(5):793-5. doi: 10.1016/j.cell.2008.11.001.

PMID:
19041743
[PubMed - indexed for MEDLINE]
Free Article
6.

TEAD mediates YAP-dependent gene induction and growth control.

Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL.

Genes Dev. 2008 Jul 15;22(14):1962-71. doi: 10.1101/gad.1664408. Epub 2008 Jun 25.

PMID:
18579750
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Application of comparative functional genomics to identify best-fit mouse models to study human cancer.

Lee JS, Chu IS, Mikaelyan A, Calvisi DF, Heo J, Reddy JK, Thorgeirsson SS.

Nat Genet. 2004 Dec;36(12):1306-11. Epub 2004 Nov 21.

PMID:
15565109
[PubMed - indexed for MEDLINE]
8.

Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene.

Kim M, Gans JD, Nogueira C, Wang A, Paik JH, Feng B, Brennan C, Hahn WC, Cordon-Cardo C, Wagner SN, Flotte TJ, Duncan LM, Granter SR, Chin L.

Cell. 2006 Jun 30;125(7):1269-81.

PMID:
16814714
[PubMed - indexed for MEDLINE]
Free Article
9.

Comparative functional genomics for identifying models of human cancer.

Lee JS, Grisham JW, Thorgeirsson SS.

Carcinogenesis. 2005 Jun;26(6):1013-20. Epub 2005 Jan 27.

PMID:
15677630
[PubMed - indexed for MEDLINE]
Free Article
10.

Functional genomics of hepatocellular carcinoma.

Thorgeirsson SS, Lee JS, Grisham JW.

Hepatology. 2006 Feb;43(2 Suppl 1):S145-50. Review.

PMID:
16447291
[PubMed - indexed for MEDLINE]
11.

Modeling liver cancer using zebrafish: a comparative oncogenomics approach.

Lam SH, Gong Z.

Cell Cycle. 2006 Mar;5(6):573-7. Epub 2006 Mar 15. Review.

PMID:
16582610
[PubMed - indexed for MEDLINE]
Free Article
12.

EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas.

Niehof M, Borlak J.

Gastroenterology. 2008 Apr;134(4):1191-202. doi: 10.1053/j.gastro.2008.01.027. Epub 2008 Jan 17.

PMID:
18395097
[PubMed - indexed for MEDLINE]
13.

Comparative proteomics and molecular mechanical analysis in CDA-II induced therapy of LCI-D20 hepatocellular carcinoma model.

Fan HZ, Liu H, Zhang C, Gao DM, Xue Q, Chen J, Sun RX, Liu YK, Yang PY.

J Cancer Res Clin Oncol. 2009 Apr;135(4):591-602. doi: 10.1007/s00432-008-0493-0. Epub 2008 Oct 14.

PMID:
18853186
[PubMed - indexed for MEDLINE]
14.

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon.

Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC, Deng CX, Brugge JS, Haber DA.

Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12405-10. Epub 2006 Aug 7.

PMID:
16894141
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Comparative genomic classification of human hepatocellular carcinoma].

Kaposi-Novák P.

Magy Onkol. 2009 Mar;53(1):61-7. doi: 10.1556/MOnkol.53.2009.1.9. Hungarian.

PMID:
19318328
[PubMed - indexed for MEDLINE]
Free Article
16.

BNIPL-2 promotes the invasion and metastasis of human hepatocellular carcinoma cells.

Xie L, Qin W, Li J, He X, Zhang H, Yao G, Shu H, Yao M, Wan D, Gu J.

Oncol Rep. 2007 Mar;17(3):605-10.

PMID:
17273740
[PubMed - indexed for MEDLINE]
17.

Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.

Kim Y, Yoon JW, Xiao X, Dean NM, Monia BP, Marcusson EG.

Cancer Res. 2007 Apr 15;67(8):3583-93.

PMID:
17440069
[PubMed - indexed for MEDLINE]
Free Article
18.

Mobility and integration sites of a murine C57BL/6 melanoma endogenous retrovirus involved in tumor progression in vivo.

Pothlichet J, Mangeney M, Heidmann T.

Int J Cancer. 2006 Oct 15;119(8):1869-77.

PMID:
16708391
[PubMed - indexed for MEDLINE]
19.

Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.

Kim TM, Yim SH, Shin SH, Xu HD, Jung YC, Park CK, Choi JY, Park WS, Kwon MS, Fiegler H, Carter NP, Rhyu MG, Chung YJ.

Int J Cancer. 2008 Dec 15;123(12):2808-15. doi: 10.1002/ijc.23901.

PMID:
18803288
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

MycN is a transcriptional regulator of livin in neuroblastoma.

Dasgupta A, Peirce SK, Findley HW.

Oncol Rep. 2009 Oct;22(4):831-5.

PMID:
19724862
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk